A Fontana
Overview
Explore the profile of A Fontana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
573
Citations
8276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schettini F, Gattazzo F, Nucera S, Rubio Garcia E, Lopez-Aladid R, Morelli L, et al.
Cancer Treat Rev
. 2024 Oct;
131:102844.
PMID: 39427380
No abstract available.
2.
Bengala C, Bettelli S, Bertolini F, Sartori G, Fontana A, Malavasi N, et al.
Br J Cancer
. 2024 Aug;
131(5):954.
PMID: 39117801
No abstract available.
3.
Arecco L, Bruzzone M, Bas R, Kim H, Di Meglio A, Bernstein-Molho R, et al.
Ann Oncol
. 2024 Jun;
35(9):792-804.
PMID: 38908482
Background: Hormone receptor expression is a known positive prognostic and predictive factor in breast cancer; however, limited evidence exists on its prognostic impact on prognosis of young patients harboring a...
4.
Trevisan B, Pepe F, Vallini I, Montagna E, Amoroso D, Berardi R, et al.
Sci Rep
. 2023 Jul;
13(1):12255.
PMID: 37507480
Nowadays, treatment of metastatic breast cancer (MBC) has been enriched with novel therapeutical strategies. Metronomic chemotherapy (mCHT) is a continuous and frequent administration of chemotherapy at a lower dose and...
5.
Fontana A, Vinci G, Ronchi L, Mocchiutti A, Muscio G, Visentini P, et al.
Sci Rep
. 2023 May;
13(1):8848.
PMID: 37258555
Prehistoric monuments often constitute evident landmarks and sometimes, after falling into disuse, fascinated local people enough to stimulate speculations about their origin over time. According to legend, the Hill of...
6.
Giuffrida G, Crisafulli S, Ferrau F, Fontana A, Alessi Y, Calapai F, et al.
J Endocrinol Invest
. 2022 Feb;
45(6):1235-1246.
PMID: 35133616
Purpose: Cushing's disease (CD), 70% of endogenous hypercortisolism cases, is a rare disease caused by adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas. To date, no systematic reviews and meta-analyses on its global...
7.
Del Re M, Omarini C, Diodati L, Palleschi M, Meattini I, Crucitta S, et al.
ESMO Open
. 2022 Feb;
7(1):100381.
PMID: 35131649
No abstract available.
8.
Cazzaniga M, Vallini I, Montagna E, Amoroso D, Berardi R, Butera A, et al.
Breast Cancer Res Treat
. 2021 Sep;
190(3):415-424.
PMID: 34546500
Purpose: Triple-negative breast cancer (TNBC) represents a subtype of breast cancer which lacks the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2): TNBC...
9.
Del Re M, Omarini C, Diodati L, Palleschi M, Meattini I, Crucitta S, et al.
ESMO Open
. 2021 Sep;
6(5):100231.
PMID: 34509802
Background: Proton-pump-inhibitors (PPIs) are frequently prescribed for the management of anticancer drug-related gastrointestinal symptoms. Palbociclib is a weak base with pH-dependent solubility and potential drug-drug interaction at the absorption level...
10.
Mamounas E, Untch M, Mano M, Huang C, Geyer Jr C, von Minckwitz G, et al.
Ann Oncol
. 2021 May;
32(8):1005-1014.
PMID: 33932503
Background: In the KATHERINE study (NCT01772472), patients with residual invasive early breast cancer (EBC) after neoadjuvant chemotherapy (NACT) plus human epidermal growth factor receptor 2 (HER2)-targeted therapy had a 50%...